GRAL stock news · GRAIL

Stories about GRAIL (GRAL) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for GRAL

Follow GRAIL (GRAL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Sep 21, 2026, 1:30 PM ET · Market
On Monday, 12 health care stocks changed a lot in price during trading.
Neutral
Shares rose 31.47% to $106.19, but the article only reports the price and market cap, so it does not change GRAIL's outlook.
Aug 10, 2026, 1:39 PM ET · Trial
Evaluation of GRAIL's premarket approval application for its multi-cancer early detection test is set by FDA panel.
Good for GRAL
GRAIL Inc. is preparing for a pivotal regulatory event as the FDA panel is set to evaluate its multi-cancer early detection test, Galleri. This meeting, scheduled for September 23, could lead to significant advancements in cancer diagnostics and positively influence GRAIL's stock performance.